<scp>VZV</scp> Prophylaxis After Allogeneic Hematopoietic Stem Cell Transplantation in Children: When to Stop?
After cessation of acyclovir prophylaxis, VZV reactivation can occur and be responsible for morbidity after allogeneic HSCT. This study suggests that the proportion of CD4+ lymphocytes and the CD4<sup>+</sup>/CD8<sup>+</sup> ratio can inform decisions about the duration of acyclovir prophylaxis after allogeneic HSCT to prevent VZV reactivation.
Authors
- Julien Labreuche (ORCID: https://orcid.org/0000-0002-3384-0423)
- Wadih Abou‐Chahla
- Pauline Navarin
- Fanny Gonzales (ORCID: https://orcid.org/0000-0003-1093-351X)
- Nassima Ramdane (ORCID: https://orcid.org/0000-0002-2524-4779)
- Brigitte Nelken (ORCID: https://orcid.org/0000-0003-1048-1517)
- Eva de Berranger (ORCID: https://orcid.org/0000-0001-8866-2831)
- A. Derache (ORCID: https://orcid.org/0000-0003-2378-5739)
- Bénedicte Bruno
Institutions
- Université de Lille (FR)
- Lille’s Cardiology Hospital (FR)
- Cancer Research And Biostatistics (US)
Publication Details
- Journal
- Cancer Reports
- Published
- 2024-11-01
- DOI
- https://doi.org/10.1002/cnr2.70015
- Citations
- 3
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 1.16